JAMA Medical News

← JAMA Medical News9 Oct · 6 min

The Black Market for Investigational GLP-1 Drugs

The Black Market for Investigational GLP-1 Drugs9 Oct6 min

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain."

Related Content:

Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain